Skip Navigation LinksHome > May/June 2014 - Volume 20 - Issue 3 > Cost-Utility of Routine Endometrial Evaluation Before Le For...
Female Pelvic Medicine & Reconstructive Surgery:
doi: 10.1097/SPV.0000000000000043
Original Article

Cost-Utility of Routine Endometrial Evaluation Before Le Fort Colpocleisis

Kandadai, Padma MD; Flynn, Michael MD, MHS; Zweizig, Susan MD; Patterson, Danielle MD, MSc

Journal Club
Journal Club Q and A
Collapse Box


Introduction: Routine preoperative evaluation of the endometrium before Le Fort colpocleisis is often recommended. There are no data, however, to support this practice. In select patients, it may not be a necessary addition to the preoperative evaluation of Le Fort colpocleisis.

Methods: A decision analysis model was created to compare uterine evaluation, by either endometrial (EM) biopsy or transvaginal ultrasound, to no evaluation for a hypothetical cohort of women undergoing Le Fort colpocleisis. We assumed the absence of risk factors for EM cancer. Probabilities and health outcome utilities were obtained from literature review. Medicare charges were used to estimate cost in 2012 US dollars. Cost-utility analysis was performed using US recommendations from a health plan perspective.

Results: At willingness-to-pay thresholds of $50,000 and $100,000, no evaluation is superior to both biopsy and ultrasound. At a 64% probability of cancer, biopsy is more cost-effective than no evaluation and ultrasound.

Conclusions: Compared to biopsy and ultrasound, in low-risk women, no EM evaluation before Le Fort colpocleisis demonstrates superior cost-utility.

Copyright © 2014 Wolters Kluwer Health, Inc. All rights reserved.


Article Tools


Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.